Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $1.73 in the last session, up 0.58% from day before closing price of $1.72. In other words, the price has increased by $0.58 from its previous closing price. On the day, 1.16 million shares were traded.
Ratios:
We take a closer look at TSHA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 42.58 while its Price-to-Book (P/B) ratio in mrq is 4.96.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is 4.07%, while the 200-Day Moving Average is calculated to be -20.37%.
Shares Statistics:
A total of 204.94M shares are outstanding, with a floating share count of 157.70M. Insiders hold about 23.07% of the company’s shares, while institutions hold 77.27% stake in the company.
